Safety and efficacy with drug-eluting stent in ST-segment elevation and non-ST-segment elevation myocardial infarction

Clinical Cardiology

Volumn 29, Issue 5, 2006, Pages 199-203

  Park, Chang Bum ^a   Lee, Cheol Whan ^a   Lee, Bong Ki ^a   Kim, Young Hak ^a   Hong, Myeong Ki ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan   (South Korea)

Author keywords

Clinical outcome; Myocardial infarction; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; STATINE DERIVATIVE;

ADULT; AGED; ARTICLE; BARE METAL STENT; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION; ST SEGMENT ELEVATION; STENT; THROMBOSIS; TREATMENT INDICATION;

CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SAFETY; STENTS; TREATMENT OUTCOME;

EID: 33646507906     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960290506     Document Type: Article

References (18)

1. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ: Comparison of angioplasty with stenting, with or without abciximab, acute myocardial infarction. N Engl J Med 2002;346:957-966
2. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartollmei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC: Stent primary angioplasty in myocardial infarction study group. Coronary angioplasty with or without stem implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-1956
3. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003;361:13-20
4. Odell A, Dudnason T, Andersson T, Jidbratt H, Grip L: One-year outcome after percutaneous coronary intervention for stable and unstable angina pectoris with or without application of general usage of stents in unselected European patient groups. Am J Cardiol 2002;90:112-118
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, for the SIRIUS Investigators: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323
6. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, for the TAXUS-IV investigators: Polymer-based, paclitaxel-eluting stents in patients with coronary artery disease. N Engl J Med 2004;350:221-231
7. Mark DS, Ratko TA, Matuszewski KA, Oinonen MJ, Cummings JP. Clinical and financial impact of drug eluting stents: The US academic experience. J Am Coll Cardiol 2005;45(suppl A):73A
8. Antman EM, Braunwald E: ST-elevation myocardial infarction: Pathology, pathophysiology, and clinical features. In Braunwald's Heart Disease, 7th ed. (Eds. Zipes DP, Libby P, Bonow RO, Braunwald E.), pp. 1141-1165. Philadelphia: WB Saunders, 2005
9. Barbinska A, Markell MS, Salifu MO, Akord M, Ehrlich YH, Komecki E: Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant 1998;13:3153-3159
10. Jeanmart H, Malo O, Carrier M, Nickner C, Desjardins N, Perrault LP: Comparative study of cyclosporine and tacrolimus vs. newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. J Heart Lung Transplant 2002;21:990-998
11. Virmani R, Farb A, Kolodgie FD: Histopathologic alterations after endovascular radiation and antiproliferative stents: Similarities and differences. Herz 2002;27:1-6
12. Lemos PA, Saia F, Hoye A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, Feyter P, Domburg RT, Serruys PW: Short-and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare metal stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708
13. Moses JW, Mehran R, Nikolsky E, Lasala JM, Corey W, Albin G, Hirsch C, Leon MB, Russel ME, Ellis ST, Stone GW: Outcomes with the paclitaxel-eluting stent in patient with acute coronary syndromes: Analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005;45:1165-1171
14. Weber F, Schneider H, Schwarz C, Holzhausen C, Petzsch M, Nienaber CA: Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction. Z Kardiol 2004;93:938-943
15. Cheneau E, Rha SW, Kuchulakanti PK, Stabile E, Kinnaird T, Torguson R, Pichard AD, Satler LF, Kent KM, Waksman R: Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Cathet Cardiovasc Intervent 2005;65:469-472
16. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107: 381-383
17. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R, and the STRATEGY Investigators: Tirofiban and sirolimus-eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction. J Am Med Assoc 2005;293:2l09-2l17
18. Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, McFadden E, Hofma SH, Giessen WJ, Feyter PI, Domburg RT, Serruys PW; Sirolimus-eluting stenting implantation in ST-elevation acute myocardial infarction. Circulation 2003;108:1927-1929